[SCHEDULE 13G/A] Staar Surgical Co SEC Filing
Armistice Capital, LLC and Steven Boyd report beneficial ownership of 2,812,000 shares of STAAR SURGICAL CO common stock, representing 5.67% of the class. The filing states that Armistice Capital is the investment manager of Armistice Capital Master Fund Ltd., the direct holder of the shares, and that Armistice exercises shared voting and dispositive power over those securities. Neither reporting person holds sole voting or dispositive power. The percentage is calculated using 49,553,035 shares outstanding as of July 30, 2025. The filing includes a certification that the shares were acquired in the ordinary course of business and not to influence control of the issuer.
Armistice Capital, LLC e Steven Boyd dichiarano la titolarit脿 effettiva di 2.812.000 azioni ordinarie di STAAR SURGICAL CO, corrispondenti al 5,67% della classe. La comunicazione precisa che Armistice Capital 猫 il gestore degli investimenti di Armistice Capital Master Fund Ltd., il detentore diretto delle azioni, e che Armistice esercita poteri condivisi di voto e di disposizione su tali titoli. Nessuno dei soggetti segnalanti detiene poteri di voto o di disposizione esclusivi. La percentuale 猫 calcolata su 49.553.035 azioni in circolazione al 30 luglio 2025. La dichiarazione contiene inoltre una certificazione che le azioni sono state acquisite nell'ordinaria attivit脿 di gestione e non con l'intento di influenzare il controllo dell'emittente.
Armistice Capital, LLC y Steven Boyd informan la propiedad beneficiaria de 2.812.000 acciones ordinarias de STAAR SURGICAL CO, que representan el 5,67% de la clase. El documento indica que Armistice Capital es el gestor de inversiones de Armistice Capital Master Fund Ltd., el titular directo de las acciones, y que Armistice ejerce poderes compartidos de voto y disposici贸n sobre esos valores. Ninguna de las personas que informan tiene poder exclusivo de voto o disposici贸n. El porcentaje se calcula sobre 49.553.035 acciones en circulaci贸n a fecha del 30 de julio de 2025. El informe incluye adem谩s una certificaci贸n de que las acciones se adquirieron en el curso habitual del negocio y no para influir en el control del emisor.
Armistice Capital, LLC鞕� Steven Boyd電� STAAR SURGICAL CO 氤错喌欤� 2,812,000欤�(頃措嫻 韥措灅鞀れ潣 5.67%)鞚� 鞁れ鞝� 靻岇湢毳� 氤搓碃頃╇媹雼�. 鞝滌稖靹滊鞐� 霐半ゴ氅� Armistice Capital鞚� 欤检嫕鞚� 歆侅爲 氤挫湢頃� Armistice Capital Master Fund Ltd.鞚� 韴瀽 甏�毽瀽鞚措┌, Armistice電� 頃措嫻 歃濌秾鞐� 雽�頃� 瓿惦彊鞚� 鞚橁舶甓� 氚� 觳橂秳甓岇潉 頄夓偓頃滊嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氤搓碃 雼轨偓鞛� 欷� 鞏措姁 雸勱惮霃� 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潉 氤挫湢頃橃 鞎婌姷雼堧嫟. 牍勳湪鞚� 2025雲� 7鞗� 30鞚� 旮办 鞙犿喌 欤检嫕靾� 49,553,035欤茧ゼ 旮办鞙茧 瓿勳偘霅橃棃鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 欤检嫕鞚� 鞓侅梾瓿检爼鞐愳劀 旆摑霅橃棃鞙茧┌ 氚滍枆須岇偓鞚� 歆�氚瓣秾鞐� 鞓來枼鞚� 氙胳箻旮� 鞙勴暅 瓴冹澊 鞎勲媹霛茧姅 鞚胳霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Armistice Capital, LLC et Steven Boyd d茅clarent la propri茅t茅 b茅n茅ficiaire de 2 812 000 actions ordinaires de STAAR SURGICAL CO, repr茅sentant 5,67 % de la cat茅gorie. Le d茅p么t pr茅cise qu'Armistice Capital est le gestionnaire d'investissement d'Armistice Capital Master Fund Ltd., d茅tenteur direct des actions, et qu'Armistice exerce un pouvoir partag茅 de vote et de disposition sur ces titres. Aucun des d茅clarants ne d茅tient un pouvoir de vote ou de disposition exclusif. Le pourcentage est calcul茅 sur la base de 49 553 035 actions en circulation au 30 juillet 2025. Le dossier inclut 茅galement une certification indiquant que les actions ont 茅t茅 acquises dans le cours normal des affaires et non dans le but d'influencer le contr么le de l'茅metteur.
Armistice Capital, LLC und Steven Boyd melden die wirtschaftliche Eigent眉merschaft an 2.812.000 Aktien der STAAR SURGICAL CO Stammaktien, was 5,67% der Klasse entspricht. Die Meldung besagt, dass Armistice Capital als Investmentmanager des direkten Aktieninhabers Armistice Capital Master Fund Ltd. fungiert und dass Armistice gemeinsame Stimm- und Verf眉gungsmacht 眉ber diese Wertpapiere aus眉bt. Keine der meldenden Personen h盲lt alleinige Stimm- oder Verf眉gungsmacht. Der Prozentsatz wurde auf Basis von 49.553.035 ausstehenden Aktien zum 30. Juli 2025 berechnet. Die Einreichung enth盲lt zudem eine Best盲tigung, dass die Aktien im normalen Gesch盲ftsverlauf erworben wurden und nicht mit dem Ziel, die Kontrolle 眉ber den Emittenten zu beeinflussen.
- None.
- None.
Insights
TL;DR: Armistice/Steven Boyd report a 5.67% stake with shared voting/dispositive power via an advisory relationship.
The Schedule 13G/A discloses a non-control, passive reporting position just above the 5% threshold that triggers public reporting. The holding is registered in the Master Fund while Armistice, as investment manager, and Mr. Boyd, as managing member, report shared voting and dispositive authority over 2,812,000 shares. The filing cites 49,553,035 shares outstanding as the denominator; the nature of acquisition is certified as ordinary-course, not for control. For investors, this is a material ownership disclosure but not a control-related filing.
TL;DR: Disclosure shows manager-led beneficial reporting and explicit Master Fund disclaimer of direct beneficial ownership.
The document clarifies governance lines: the Master Fund is the record holder while Armistice exercises voting/investment power under an investment management agreement, and the Master Fund disclaims direct beneficial ownership because it cannot vote or dispose of the shares independently. This allocation of authority is important for meeting reporting rules and for understanding where voting influence legally resides. The joint filing statement centralizes amendment responsibility between the parties.
Armistice Capital, LLC e Steven Boyd dichiarano la titolarit脿 effettiva di 2.812.000 azioni ordinarie di STAAR SURGICAL CO, corrispondenti al 5,67% della classe. La comunicazione precisa che Armistice Capital 猫 il gestore degli investimenti di Armistice Capital Master Fund Ltd., il detentore diretto delle azioni, e che Armistice esercita poteri condivisi di voto e di disposizione su tali titoli. Nessuno dei soggetti segnalanti detiene poteri di voto o di disposizione esclusivi. La percentuale 猫 calcolata su 49.553.035 azioni in circolazione al 30 luglio 2025. La dichiarazione contiene inoltre una certificazione che le azioni sono state acquisite nell'ordinaria attivit脿 di gestione e non con l'intento di influenzare il controllo dell'emittente.
Armistice Capital, LLC y Steven Boyd informan la propiedad beneficiaria de 2.812.000 acciones ordinarias de STAAR SURGICAL CO, que representan el 5,67% de la clase. El documento indica que Armistice Capital es el gestor de inversiones de Armistice Capital Master Fund Ltd., el titular directo de las acciones, y que Armistice ejerce poderes compartidos de voto y disposici贸n sobre esos valores. Ninguna de las personas que informan tiene poder exclusivo de voto o disposici贸n. El porcentaje se calcula sobre 49.553.035 acciones en circulaci贸n a fecha del 30 de julio de 2025. El informe incluye adem谩s una certificaci贸n de que las acciones se adquirieron en el curso habitual del negocio y no para influir en el control del emisor.
Armistice Capital, LLC鞕� Steven Boyd電� STAAR SURGICAL CO 氤错喌欤� 2,812,000欤�(頃措嫻 韥措灅鞀れ潣 5.67%)鞚� 鞁れ鞝� 靻岇湢毳� 氤搓碃頃╇媹雼�. 鞝滌稖靹滊鞐� 霐半ゴ氅� Armistice Capital鞚� 欤检嫕鞚� 歆侅爲 氤挫湢頃� Armistice Capital Master Fund Ltd.鞚� 韴瀽 甏�毽瀽鞚措┌, Armistice電� 頃措嫻 歃濌秾鞐� 雽�頃� 瓿惦彊鞚� 鞚橁舶甓� 氚� 觳橂秳甓岇潉 頄夓偓頃滊嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氤搓碃 雼轨偓鞛� 欷� 鞏措姁 雸勱惮霃� 雼弲 鞚橁舶甓岇澊雮� 雼弲 觳橂秳甓岇潉 氤挫湢頃橃 鞎婌姷雼堧嫟. 牍勳湪鞚� 2025雲� 7鞗� 30鞚� 旮办 鞙犿喌 欤检嫕靾� 49,553,035欤茧ゼ 旮办鞙茧 瓿勳偘霅橃棃鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 欤检嫕鞚� 鞓侅梾瓿检爼鞐愳劀 旆摑霅橃棃鞙茧┌ 氚滍枆須岇偓鞚� 歆�氚瓣秾鞐� 鞓來枼鞚� 氙胳箻旮� 鞙勴暅 瓴冹澊 鞎勲媹霛茧姅 鞚胳霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Armistice Capital, LLC et Steven Boyd d茅clarent la propri茅t茅 b茅n茅ficiaire de 2 812 000 actions ordinaires de STAAR SURGICAL CO, repr茅sentant 5,67 % de la cat茅gorie. Le d茅p么t pr茅cise qu'Armistice Capital est le gestionnaire d'investissement d'Armistice Capital Master Fund Ltd., d茅tenteur direct des actions, et qu'Armistice exerce un pouvoir partag茅 de vote et de disposition sur ces titres. Aucun des d茅clarants ne d茅tient un pouvoir de vote ou de disposition exclusif. Le pourcentage est calcul茅 sur la base de 49 553 035 actions en circulation au 30 juillet 2025. Le dossier inclut 茅galement une certification indiquant que les actions ont 茅t茅 acquises dans le cours normal des affaires et non dans le but d'influencer le contr么le de l'茅metteur.
Armistice Capital, LLC und Steven Boyd melden die wirtschaftliche Eigent眉merschaft an 2.812.000 Aktien der STAAR SURGICAL CO Stammaktien, was 5,67% der Klasse entspricht. Die Meldung besagt, dass Armistice Capital als Investmentmanager des direkten Aktieninhabers Armistice Capital Master Fund Ltd. fungiert und dass Armistice gemeinsame Stimm- und Verf眉gungsmacht 眉ber diese Wertpapiere aus眉bt. Keine der meldenden Personen h盲lt alleinige Stimm- oder Verf眉gungsmacht. Der Prozentsatz wurde auf Basis von 49.553.035 ausstehenden Aktien zum 30. Juli 2025 berechnet. Die Einreichung enth盲lt zudem eine Best盲tigung, dass die Aktien im normalen Gesch盲ftsverlauf erworben wurden und nicht mit dem Ziel, die Kontrolle 眉ber den Emittenten zu beeinflussen.
FAQ
How many STAAR SURGICAL CO (STAA) shares does Armistice Capital report owning?
What voting and dispositive power does Armistice Capital have over STAA shares?
On what share count is the 5.67% ownership based?
Does the filing indicate Armistice intends to influence control of STAAR SURGICAL CO?
Who is the direct holder of the reported shares?
